Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Sediment Quality Mainstem and Tributaries, Oil Sands Region
- Halogenated Phenolic Compounds in the plasma of Detroit River AOC Brown bullhead
- Spatial distribution and seasonal variation of epiphytic cyanobacteria, filamentous algae and macrophytes in the St. Lawrence River
- Wheatley Harbour Area of Concern
- Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Review process, communications and transparency
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Overview
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Preparing a submission or supplement
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Drug establishment licences and good manufacturing practices
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Pre-positioning of COVID-19 drugs
- Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Intellectual property
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Background
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Overview
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Performance criteria
- Guidance on safety and performance specifications for filtering facepiece respirators (FFRs) during COVID-19: Other items for an interim order submission
- Moderna COVID-19 vaccine: Authorized with conditions
- Moderna COVID-19 vaccine: Continued monitoring
- Moderna COVID-19 vaccine: What you should know
- Medical devices for uses related to COVID-19
- Impact of municipal effluents and hydrological regime on myxozoan parasite communities of fish
- Oil Sands bitumen sediment exposure of Fathead minnows
- Reporting facilities – pollutant release and transfer data
- Schedule 2 - Transit Routes: Kingston Zoning By-Law (2022-62)
- Database of Environmental Quality Guidelines
- Great Lakes Mesoscale Boundary Database
- Schedule C - Airport Noise Overlay: Kingston Zoning By-Law (2022-62)
- Schedule B - Wellhead Protection Area: Kingston Zoning By-Law (2022-62)
- Indices based on daily temperature and precipitation
- Integrated pan-Arctic Snow Melt Onset from Satellite Measurements
- The Canadian Regional Climate Model Large Ensemble
- Basin averaged CanRCM4 variables for Western Canada
- Pelagic Seabird Atlas, West Coast of Canada
- TO2015 Pan and Parapan American Games Atmospheric Monitoring Observations
- 2021 City of Mississauga - Parks
- Foothills Orographic Precipitation Experiment (FOPEX)
- Survey of Intellectual Property Awareness and Use – Data Tables
- NAV CANADA - TO2015 Pan and Parapan American Games
- Mesonet Marine Stations Observations: Buoy 45155 - TO2015 Pan and Parapan American Games
- Pelagic Seabird Atlas, West Coast of Canada - Attribute Data, 2009
- Guidance for market authorization requirements for COVID-19 vaccines: Labelling and post-market requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants
- Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements
- Guidance for market authorization requirements for COVID-19 vaccines: Overview
- FDA guidance: Template for manufacturers of molecular and antigen diagnostic COVID-19 tests for non-laboratory use
- Exceptional importation and sale of medical devices in relation to COVID-19: Overview
- Drugs and vaccines for COVID-19: List of authorized clinical trials
- Exceptional importation and sale of drugs in relation to COVID-19: Overview
- Drugs and vaccines for COVID-19
- Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders